Masimo Corporation (NASDAQ:MASI) was the recipient of a large decrease in short interest in May. As of May 15th, there was short interest totalling 2,329,761 shares, a decrease of 24.7% from the April 28th total of 3,095,463 shares. Currently, 4.9% of the company’s shares are sold short. Based on an average daily trading volume, of 1,192,215 shares, the short-interest ratio is presently 2.0 days.
In other news, CEO Joe E. Kiani sold 145,841 shares of the company’s stock in a transaction that occurred on Monday, May 1st. The stock was sold at an average price of $102.37, for a total transaction of $14,929,743.17. Following the transaction, the chief executive officer now directly owns 165,082 shares of the company’s stock, valued at $16,899,444.34. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Yongsam Lee sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, April 19th. The stock was sold at an average price of $95.00, for a total value of $950,000.00. Following the transaction, the executive vice president now directly owns 79,000 shares in the company, valued at $7,505,000. The disclosure for this sale can be found here. Insiders have sold a total of 562,201 shares of company stock worth $56,005,386 over the last 90 days. Company insiders own 16.60% of the company’s stock.
Large investors have recently made changes to their positions in the company. Skandinaviska Enskilda Banken AB publ acquired a new stake in shares of Masimo Corporation during the first quarter valued at $21,487,000. Caxton Associates LP purchased a new position in Masimo Corporation during the first quarter valued at about $466,000. Metropolitan Life Insurance Co. NY boosted its position in Masimo Corporation by 141.6% in the first quarter. Metropolitan Life Insurance Co. NY now owns 69,170 shares of the medical equipment provider’s stock valued at $6,451,000 after buying an additional 40,536 shares in the last quarter. Paloma Partners Management Co boosted its position in Masimo Corporation by 134.3% in the first quarter. Paloma Partners Management Co now owns 24,543 shares of the medical equipment provider’s stock valued at $2,288,000 after buying an additional 14,068 shares in the last quarter. Finally, AQR Capital Management LLC boosted its position in Masimo Corporation by 0.3% in the first quarter. AQR Capital Management LLC now owns 137,695 shares of the medical equipment provider’s stock valued at $12,841,000 after buying an additional 462 shares in the last quarter. Institutional investors and hedge funds own 83.47% of the company’s stock.
A number of equities research analysts recently commented on MASI shares. Wedbush reissued an “outperform” rating and issued a $95.00 price target on shares of Masimo Corporation in a research report on Monday, February 27th. Piper Jaffray Companies lowered Masimo Corporation from an “overweight” rating to a “neutral” rating in a research report on Thursday, March 16th. Finally, Zacks Investment Research lowered Masimo Corporation from a “strong-buy” rating to a “hold” rating in a research report on Thursday, May 11th. Five equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $78.00.
Masimo Corporation (NASDAQ MASI) traded down 0.21% on Tuesday, hitting $92.88. The stock had a trading volume of 517,511 shares. The firm has a 50-day moving average of $89.28 and a 200 day moving average of $83.55. The company has a market capitalization of $4.75 billion, a price-to-earnings ratio of 15.77 and a beta of 0.89. Masimo Corporation has a 52 week low of $48.07 and a 52 week high of $104.71.
Masimo Corporation (NASDAQ:MASI) last announced its earnings results on Wednesday, May 3rd. The medical equipment provider reported $0.82 earnings per share for the quarter, topping the consensus estimate of $0.60 by $0.22. Masimo Corporation had a net margin of 44.86% and a return on equity of 24.19%. The business had revenue of $186.30 million during the quarter, compared to the consensus estimate of $184.14 million. During the same quarter in the prior year, the firm earned $0.53 earnings per share. The business’s quarterly revenue was up 8.8% compared to the same quarter last year. On average, analysts predict that Masimo Corporation will post $2.66 earnings per share for the current year.
ILLEGAL ACTIVITY NOTICE: “Short Interest in Masimo Corporation (MASI) Drops By 24.7%” was first posted by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this report on another publication, it was stolen and reposted in violation of international trademark & copyright law. The correct version of this report can be read at https://sportsperspectives.com/2017/06/20/masimo-co-masi-short-interest-update-updated-updated-updated.html.
About Masimo Corporation
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.